Many recipients of retrievable IVC filters, designed to protect against pulmonary embolisms, may have complications and yet not even be aware that there is a danger associated with the devices being left in place past a specified period of time. Devices left in place longer than 50 days may increase the risk of blood clots and deep vein thrombosis as well as other complications that include migration, fracture, embolization, perforation and the inability to remove the devices.

Individuals who have suffered complications or life threatening injuries as a result of defective IVC filters have many legal options. Consumer Safety Watch offers free legal assistance and can help place injured victims and their families with qualified law firms that will accept their cases at no cost unless there is a favorable verdict or settlement.

Retrievable IVC Filters meant to be a temporary solution to pulmonary embolism risks in many situation do not get removed or become impossible to remove leading to additional serious complications, according to the IVC Filter Legal Help Center.

If not removed within 30-45 days, a dangerously high rate of so-called retrievable IVC filters, generally implanted to prevent pulmonary embolisms, experience complications that can lead to additional medical procedures, serious injury and death, and the risk generally outweighs any benefit, according to Ford and Associates Nationwide Legal Services.

The controversial devices are linked to at least 27 deaths and over 300 additional injuries. Many devices can become difficult or impossible to retrieve if left in for more than 30-45 days after implant.

A recent three part NBC News Investigation has raised serious concerns regarding the safety and FDA Approval Process of some IVC Filters.

According to a recent NBC News Investigation on the dangers associated with certain IVC filters, Bard may have even hired a public relations firm to help with a cover up while delaying pulling the dangerous devices from the market.

Runners in the upcoming Allscripts Tobacco Road Marathon can hit the trail to help raise funds to Stop the Clot® and support the educational efforts of the National Blood Clot Alliance.

Nearly 300 official charity partners are expected to participate in the 2015 TCS New York City Marathon this year. The National Blood Clot Alliance has ten available spots on their Team Stop the Clot® this year.

Michael B. Streiff, MD, FACP, selected to head up prestigious group of medical and scientific advisors to NBCA.

The National Blood Clot Alliance will continue its long-standing collaboration with the Centers for Disease Control and Prevention (CDC), as it has been awarded another five-year CDC Cooperative Agreement to raise public awareness about blood clots.

World Thrombosis Day is a global effort to raise awareness about deadly blood clots. In the U.S., up to 300,000 people die each year due to blood clots, which is greater than the number of deaths due to AIDS, breast cancer, and car crashes combined.